-->
The traumatic brain injury (TBI) market is expected to witness significant growth, with revenues projected to increase from USD 2.5 billion in 2024 to USD 4.7 billion by 2033, registering a strong CAGR of 7.2% during the forecast period.
Complementary and alternative medicine market was valued at US$ 193.36 billion in 2024 and is projected to hit the market valuation of US$ 1,282.70 billion by 2033 at a CAGR of 23.56% during the forecast period 2025–2033.
Point-of-care testing market was valued at US$ 46.48 billion in 2024 and is projected to hit the market valuation of US$ 85.55 billion by 2033 at a CAGR of 7.33% during the forecast period 2025–2033.
The glioblastoma multiforme treatment market is projected to grow from USD 3.0 billion in 2024 to USD 6.1 billion by 2033, registering a compound annual growth rate (CAGR) of 8.5% during the forecast period.
Hernia repair devices market was valued at US$ 4.69 billion in 2024 and is projected to hit the market valuation of US$ 6.57 billion by 2033 at a CAGR of 4.32% during the forecast period 2025–2033.
Amyotrophic lateral sclerosis treatment market is projected to grow from USD 724.5 million in 2024 to USD 1,234.5 million by 2033, expanding at a compound annual growth rate (CAGR) of 6.1% during the forecast period.
Japan facial injectables market was valued at US$ 508.18 million in 2024 and is projected to hit the market valuation of US$ 1,121.31 million by 2033 at a CAGR of 9.52% during the forecast period 2025–2033.
Elastomeric infusion pumps market was valued at US$ 741.56 million in 2024 and is projected to hit the market valuation of US$ 1,357.40 million by 2033 at a CAGR of 7.85% during the forecast period 2025–2033.
Medical crowdfunding market was valued at US$ 3.47 billion in 2024 and is projected to hit the market valuation of US$ 13.55 billion by 2033 at a CAGR of 16.32% during the forecast period 2025–2033.